Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Webb

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 30, 2009
Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumorsMario Durán-Prado, Manuel D Gahete, Antonio J Martínez-Fuentes, et al.
European Journal of Endocrinology|February 7, 2023
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndromeVincent Amodru, Amandine Ferriere, Antoine Tabarin, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H)Myriam Rosilio, Werner F Blum, David J Edwards, et al.
Acta Otorrinolaringologica Espanola|January 22, 2013
Endoscopic surgery in the skull base unit: experience in the first 72 casesJuan R Gras-Cabrerizo, Fernando Muñoz-Hernández, Joan R Montserrat-Gili, et al.
Scientific Reports|January 17, 2025
Oxytocin levels in response to CRH administration in hypopituitarism and hypothalamic damage: a randomized, crossover, placebo-controlled trialQueralt Asla, Maite Garrido, Eulàlia Urgell, et al.
Pituitary|September 10, 2017
Development of ACRODAT<sup>®</sup>, a new software medical device to assess disease activity in patients with acromegalyAart J van der Lely, Roy Gomez, Andreas Pleil, et al.
European Journal of Endocrinology|July 27, 2021
Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomasIdoia Martínez de LaPiscina, Nancy Portillo Najera, Itxaso Rica, et al.
Endocrine-Related Cancer|October 5, 2022
Corticotroph tumor progression after bilateral adrenalectomy: data from ERCUSYNElena Valassi, Frédéric Castinetti, Amandine Ferriere, et al.
Pituitary|April 7, 2012
Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)Gemma Sesmilo, Sonia Gaztambide, Eva Venegas, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2008
Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretionRafael Vazquez-Martinez, Antonio J Martinez-Fuentes, Marina R Pulido, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Endocrinology and Metabolism|April 30, 2009
Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumorsMario Durán-Prado, Manuel D Gahete, Antonio J Martínez-Fuentes, et al.
European Journal of Endocrinology|February 7, 2023
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndromeVincent Amodru, Amandine Ferriere, Antoine Tabarin, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H)Myriam Rosilio, Werner F Blum, David J Edwards, et al.
Acta Otorrinolaringologica Espanola|January 22, 2013
Endoscopic surgery in the skull base unit: experience in the first 72 casesJuan R Gras-Cabrerizo, Fernando Muñoz-Hernández, Joan R Montserrat-Gili, et al.
Scientific Reports|January 17, 2025
Oxytocin levels in response to CRH administration in hypopituitarism and hypothalamic damage: a randomized, crossover, placebo-controlled trialQueralt Asla, Maite Garrido, Eulàlia Urgell, et al.
Pituitary|September 10, 2017
Development of ACRODAT<sup>®</sup>, a new software medical device to assess disease activity in patients with acromegalyAart J van der Lely, Roy Gomez, Andreas Pleil, et al.
European Journal of Endocrinology|July 27, 2021
Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomasIdoia Martínez de LaPiscina, Nancy Portillo Najera, Itxaso Rica, et al.
Endocrine-Related Cancer|October 5, 2022
Corticotroph tumor progression after bilateral adrenalectomy: data from ERCUSYNElena Valassi, Frédéric Castinetti, Amandine Ferriere, et al.
Pituitary|April 7, 2012
Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)Gemma Sesmilo, Sonia Gaztambide, Eva Venegas, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2008
Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretionRafael Vazquez-Martinez, Antonio J Martinez-Fuentes, Marina R Pulido, et al.
Pageof 18